107 related articles for article (PubMed ID: 18584335)
1. Inhibitors of GSK-3 prevent corticosterone from inducing COX-1 expression in cardiomyocytes.
Sun H; Chen QM
Cardiovasc Toxicol; 2008; 8(2):93-100. PubMed ID: 18584335
[TBL] [Abstract][Full Text] [Related]
2. P38 MAPK mediates COX-2 gene expression by corticosterone in cardiomyocytes.
Sun H; Xu B; Inoue H; Chen QM
Cell Signal; 2008 Nov; 20(11):1952-9. PubMed ID: 18657608
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activity of glycogen synthase kinase-3beta: positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells.
Nemoto T; Yokoo H; Satoh S; Yanagita T; Sugano T; Yoshikawa N; Maruta T; Kobayashi H; Wada A
Brain Res; 2006 Sep; 1110(1):1-12. PubMed ID: 16870161
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids induce cyclooxygenase 1 expression in cardiomyocytes: role of glucocorticoid receptor and Sp3 transcription factor.
Sun H; Sheveleva E; Chen QM
Mol Endocrinol; 2008 Sep; 22(9):2076-84. PubMed ID: 18599619
[TBL] [Abstract][Full Text] [Related]
6. Chronic lithium treatment up-regulates cell surface Na(V)1.7 sodium channels via inhibition of glycogen synthase kinase-3 in adrenal chromaffin cells: enhancement of Na(+) influx, Ca(2+) influx and catecholamine secretion after lithium withdrawal.
Yanagita T; Maruta T; Nemoto T; Uezono Y; Matsuo K; Satoh S; Yoshikawa N; Kanai T; Kobayashi H; Wada A
Neuropharmacology; 2009 Sep; 57(3):311-21. PubMed ID: 19486905
[TBL] [Abstract][Full Text] [Related]
7. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes.
Tseng AS; Engel FB; Keating MT
Chem Biol; 2006 Sep; 13(9):957-63. PubMed ID: 16984885
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 1 gene expression is required for cardiomyocyte proliferation and is repressed by Sp3.
Seyed M; Dimario JX
J Mol Cell Cardiol; 2008 Mar; 44(3):510-9. PubMed ID: 18275970
[TBL] [Abstract][Full Text] [Related]
9. Prevention of rat cortical neurons from prostaglandin E2-induced apoptosis by glycogen synthase kinase-3 inhibitors.
Takadera T; Ohyashiki T
Neurosci Lett; 2006 May; 400(1-2):105-9. PubMed ID: 16504398
[TBL] [Abstract][Full Text] [Related]
10. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glycogen synthase kinase-3 enhances the expression of alkaline phosphatase and insulin-like growth factor-1 in human primary dermal papilla cell culture and maintains mouse hair bulbs in organ culture.
Yamauchi K; Kurosaka A
Arch Dermatol Res; 2009 Jun; 301(5):357-65. PubMed ID: 19238412
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3 regulation of chromatin segregation and cytokinesis in mouse preimplantation embryos.
Acevedo N; Wang X; Dunn RL; Smith GD
Mol Reprod Dev; 2007 Feb; 74(2):178-88. PubMed ID: 16941690
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of GSK-3 reduces prostaglandin E2 production by decreasing the expression levels of COX-2 and mPGES-1 in monocyte/macrophage lineage cells.
Noma T; Takahashi-Yanaga F; Arioka M; Mori Y; Sasaguri T
Biochem Pharmacol; 2016 Sep; 116():120-9. PubMed ID: 27453433
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.
Beurel E; Blivet-Van Eggelpoël MJ; Kornprobst M; Moritz S; Delelo R; Paye F; Housset C; Desbois-Mouthon C
Biochem Pharmacol; 2009 Jan; 77(1):54-65. PubMed ID: 18938143
[TBL] [Abstract][Full Text] [Related]
15. Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
Park HJ; Kim HJ; Bae GS; Seo SW; Kim DY; Jung WS; Kim MS; Song MY; Kim EK; Kwon KB; Hwang SY; Song HJ; Park CS; Park RK; Chong MS; Park SJ
Hear Res; 2009 Nov; 257(1-2):53-62. PubMed ID: 19666099
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
17. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
[TBL] [Abstract][Full Text] [Related]
18. LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism.
Sun H; Xu B; Sheveleva E; Chen QM
Toxicol Appl Pharmacol; 2008 Oct; 232(1):25-32. PubMed ID: 18657281
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
Lamarre M; Desrosiers RR
Neuropharmacology; 2008 Oct; 55(5):669-76. PubMed ID: 18582478
[TBL] [Abstract][Full Text] [Related]
20. GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes.
Evenson AR; Fareed MU; Menconi MJ; Mitchell JC; Hasselgren PO
Int J Biochem Cell Biol; 2005 Oct; 37(10):2226-38. PubMed ID: 16051512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
